{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:12:35Z","timestamp":1792091555399,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,12,16]],"date-time":"2010-12-16T00:00:00Z","timestamp":1292457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00702-010-0526-0","type":"journal-article","created":{"date-parts":[[2010,12,15]],"date-time":"2010-12-15T11:54:48Z","timestamp":1292414088000},"page":"1703-1716","source":"Crossref","is-referenced-by-count":24,"title":["Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on l-DOPA-induced dyskinesia"],"prefix":"10.1007","volume":"118","author":[{"given":"Andrzej","family":"Dekundy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Gravius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Hechenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Pietraszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Tober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"van der Elst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Mela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Danysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,16]]},"reference":[{"key":"526_CR1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/nbdi.1999.0259","volume":"6","author":"M Andersson","year":"1999","unstructured":"Andersson M, Hilbertson A, Cenci MA (1999) Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson\u2019s disease. Neurobiol Dis 6:461\u2013474","journal-title":"Neurobiol Dis"},{"issue":"Suppl. 2","key":"526_CR2","first-page":"S290","volume":"25","author":"D Berg","year":"2010","unstructured":"Berg D, Godau J, Trenkwalder C, Eggert A, Csoti I, Storch A, Gasparini F, Hariry S, Vandermeulebroecke M, Johns D, Gomez-Mancilla B (2010) AFQ056 treatment of severe levodopa-induced dyskinesias: proof of concept study. Mov Disord 25(Suppl. 2):S290","journal-title":"Mov Disord"},{"key":"526_CR3","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/mds.870130507","volume":"13","author":"PJ Blanchet","year":"1998","unstructured":"Blanchet PJ, Konitsiotis S, Chase TN (1998) Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys. Mov Disord 13:798\u2013802","journal-title":"Mov Disord"},{"key":"526_CR4","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1046\/j.1460-9568.1998.00285.x","volume":"10","author":"MA Cenci","year":"1998","unstructured":"Cenci MA, Lee CS, Bjorklund A (1998) l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur J Neurosci 10:2694\u20132706","journal-title":"Eur J Neurosci"},{"key":"526_CR5","first-page":"1337","volume":"5","author":"TJ Coderre","year":"1994","unstructured":"Coderre TJ, Yashpal K, Henry JL (1994) Specific contribution of lumbar spinal mechanisms to persistent nociceptive responses in the formalin test. Neuroreport 5:1337\u20131340","journal-title":"Neuroreport"},{"key":"526_CR6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nrn1763","volume":"6","author":"PJ Conn","year":"2005","unstructured":"Conn PJ, Battaglia G, Marino MJ, Nicoletti F (2005) Metabotropic glutamate receptors in the basal ganglia motor circuit. Nat Rev Neurosci 6:787\u2013798","journal-title":"Nat Rev Neurosci"},{"key":"526_CR7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.brainresbull.2005.12.009","volume":"69","author":"A Dekundy","year":"2006","unstructured":"Dekundy A, Pietraszek M, Schaefer D, Cenci MA, Danysz W (2006) Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson\u2019s disease. Brain Res Bull 69:318\u2013326","journal-title":"Brain Res Bull"},{"key":"526_CR8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2007.01.013","volume":"179","author":"A Dekundy","year":"2007","unstructured":"Dekundy A, Lundblad M, Danysz W, Cenci MA (2007) Modulation of l-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model. Behav Brain Res 179:76\u201389","journal-title":"Behav Brain Res"},{"key":"526_CR9","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0028-3908(99)00200-2","volume":"39","author":"S Dolan","year":"2000","unstructured":"Dolan S, Nolan AM (2000) Behavioural evidence supporting a differential role for group I and II metabotropic glutamate receptors in spinal nociceptive transmission. Neuropharmacology 39:1132\u20131138","journal-title":"Neuropharmacology"},{"key":"526_CR10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0306-4522(95)00565-X","volume":"72","author":"E Eisenberg","year":"1996","unstructured":"Eisenberg E, Vos BP, Strassman AM (1996) The peripheral antinociceptive effect of morphine in a rat model of facial pain. Neuroscience 72:519\u2013525","journal-title":"Neuroscience"},{"key":"526_CR11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0304-3959(96)03212-5","volume":"68","author":"K Fisher","year":"1996","unstructured":"Fisher K, Coderre TJ (1996) The contribution of metabotropic glutamate receptors (mGluRs) to formalin-induced nociception. Pain 68:255\u2013263","journal-title":"Pain"},{"key":"526_CR12","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/00001756-199804200-00038","volume":"9","author":"K Fisher","year":"1998","unstructured":"Fisher K, Coderre TJ (1998) Hyperalgesia and allodynia induced by intrathecal (RS)-dihydroxyphenylglycine in rats. Neuroreport 9:1169\u20131172","journal-title":"Neuroreport"},{"key":"526_CR13","first-page":"144","volume":"27","author":"CTH Friedmann","year":"1980","unstructured":"Friedmann CTH, Davis LJ, Ciccone PE, Rubin RT (1980) Phase II double blind controlled study of a new anxiolytic, fenobam (McN-3377) vs. placebo. Curr Ther Res 27:144\u2013151","journal-title":"Curr Ther Res"},{"key":"526_CR14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1471-4159.1966.tb09873.x","volume":"13","author":"J Glowinski","year":"1966","unstructured":"Glowinski J, Iverson LL (1966) Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem 13:655\u2013662","journal-title":"J Neurochem"},{"key":"526_CR15","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00702-008-0098-4","volume":"115","author":"A Gravius","year":"2008","unstructured":"Gravius A, Dekundy A, Nagel J, More L, Pietraszek M, Danysz W (2008) Investigation on tolerance development to subchronic blockade of mGluR5 in models of learning, anxiety, and levodopa-induced dyskinesia in rats. J Neural Transm 115:1609\u20131619","journal-title":"J Neural Transm"},{"key":"526_CR16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156802610790411018","volume":"10","author":"A Gravius","year":"2010","unstructured":"Gravius A, Pietraszek M, Dekundy A, Danysz W (2010) Metabotropic glutamate receptors as therapeutic targets for cognitive disorders. Curr Top Med Chem 10:187\u2013206","journal-title":"Curr Top Med Chem"},{"key":"526_CR17","unstructured":"Gregoire L, Ouattara B, Gasparini F, Bilbe G, Johns D, Vranesic I, Sahasramaman S, Gomez-Mancilla B, DiPaolo T (2009) Antidyskinetic effect of AFQ056 a novel metabotropic glutamate receptor type 5 (mGluR5) antagonist in MPTP monkeys. Soc Neurosci Abstr 39:326.15"},{"issue":"Suppl. 2","key":"526_CR18","first-page":"S281","volume":"25","author":"MP Hill","year":"2010","unstructured":"Hill MP, Girard F, Keywood C, Poli S-M, Crossmann AR, Ravenscroft P, Li Q, Bezard E, Mutel V (2010) ADX48621, a novel mGlu5 negative allosteric modulator alleviates l-DOPA-induced chorea and dystonia in the MPTP-lesioned macaque model of Parkinson\u2019s disease. Mov Disord 25(Suppl. 2):S281\u2013S282","journal-title":"Mov Disord"},{"key":"526_CR19","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1523\/JNEUROSCI.22-07-02660.2002","volume":"22","author":"LJ Hudson","year":"2002","unstructured":"Hudson LJ, Bevan S, McNair K, Gentry C, Fox A, Kuhn R, Winter J (2002) Metabotropic glutamate receptor 5 upregulation in A-fibers after spinal nerve injury: 2-methyl-6-(phenylethynyl)-pyridine (MPEP) reverses the induced thermal hyperalgesia. J Neurosci 22:2660\u20132668","journal-title":"J Neurosci"},{"key":"526_CR20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1124\/jpet.110.166629","volume":"333","author":"TH Johnston","year":"2010","unstructured":"Johnston TH, Fox SH, McIldowie MJ, Piggott MJ, Brotchie JM (2010) Reduction of l-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson\u2019s disease. J Pharmacol Exp Ther 333:865\u2013873","journal-title":"J Pharmacol Exp Ther"},{"key":"526_CR21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.nbd.2004.07.005","volume":"17","author":"C Konradi","year":"2004","unstructured":"Konradi C, Westin JE, Carta M, Eaton ME, Kuter K, Dekundy A, Lundblad M, Cenci MA (2004) Transcriptome analysis in a rat model of l-DOPA-induced dyskinesia. Neurobiol Dis 17:219\u2013236","journal-title":"Neurobiol Dis"},{"key":"526_CR22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.nbd.2007.08.011","volume":"29","author":"G Levandis","year":"2008","unstructured":"Levandis G, Bazzini E, Armentero MT, Nappi G, Blandini F (2008) Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson\u2019s disease. Neurobiol Dis 29:161\u2013168","journal-title":"Neurobiol Dis"},{"key":"526_CR23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0304-3940(02)00393-2","volume":"327","author":"DS Lorrain","year":"2002","unstructured":"Lorrain DS, Correa L, Anderson J, Varney M (2002) Activation of spinal group I metabotropic glutamate receptors in rats evokes local glutamate release and spontaneous nociceptive behaviors: effects of 2-methyl-6-(phenylethynyl)-pyridine pretreatment. Neurosci Lett 327:198\u2013202","journal-title":"Neurosci Lett"},{"key":"526_CR24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","volume":"15","author":"M Lundblad","year":"2002","unstructured":"Lundblad M, Andersson M, Winkler C, Kirik D, Wierup N, Cenci MA (2002) Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease. Eur J Neurosci 15:120\u2013132","journal-title":"Eur J Neurosci"},{"key":"526_CR25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(01)02362-X","volume":"316","author":"J Martindale","year":"2001","unstructured":"Martindale J, Bland-Ward PA, Chessell IP (2001) Inhibition of C-fibre mediated sensory transmission in the rat following intraplantar formalin. Neurosci Lett 316:33\u201336","journal-title":"Neurosci Lett"},{"key":"526_CR26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3940(96)12552-0","volume":"208","author":"WD McCall","year":"1996","unstructured":"McCall WD, Tanner KD, Levine JD (1996) Formalin induces biphasic activity in C-fibers in the rat. Neurosci Lett 208:45\u201348","journal-title":"Neurosci Lett"},{"key":"526_CR27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1471-4159.2007.04456.x","volume":"101","author":"F Mela","year":"2007","unstructured":"Mela F, Marti M, Dekundy A, Danysz W, Morari M, Cenci MA (2007) Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson\u2019s disease. J Neurochem 101:483\u2013497","journal-title":"J Neurochem"},{"key":"526_CR28","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.neuropharm.2009.12.024","volume":"58","author":"N Morin","year":"2010","unstructured":"Morin N, Gregoire L, Gomez-Mancilla B, Gasparini F, Di PT (2010) Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys. Neuropharmacology 58:981\u2013986","journal-title":"Neuropharmacology"},{"key":"526_CR78","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0014-2999(00)00263-6","volume":"397","author":"F Murray","year":"2000","unstructured":"Murray F, Kennedy J, Hutson PH, Elliot J, Huscroft I, Mohnen K, Russell MG, Grimwood S (2000) Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro. Eur J Pharmacol 397:263\u2013270","journal-title":"Eur J Pharmacol"},{"key":"526_CR29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0166-2236(00)02007-5","volume":"24","author":"V Neugebauer","year":"2001","unstructured":"Neugebauer V (2001) Peripheral metabotropic glutamate receptors: fight the pain where it hurts. Trends Neurosci 24:550\u2013552","journal-title":"Trends Neurosci"},{"key":"526_CR79","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0006-2952(64)90096-6","volume":"13","author":"S Otsuka","year":"1964","unstructured":"Otsuka S, Kobayashi Y (1964) Radioisotopic assay for monoamine oxidase determinations in human plasma. Biochem Pharmacol 13:995\u20131006","journal-title":"Biochem Pharmacol"},{"key":"526_CR30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12031-008-9137-8","volume":"38","author":"B Ouattara","year":"2009","unstructured":"Ouattara B, Belkhir S, Morissette M, Dridi M, Samadi P, Gregoire L, Meltzer LT, Di PT (2009a) Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61\u20138048 in MPTP monkeys with levodopa-induced dyskinesias. J Mol Neurosci 38:128\u2013142","journal-title":"J Mol Neurosci"},{"key":"526_CR31","doi-asserted-by":"crossref","unstructured":"Ouattara B, Gregoire L, Morissette M, Gasparini F, Vranesic I, Bilbe G, Johns DR, Rajput A, Hornykiewicz O, Rajput AH, Gomez-Mancilla B, Di PT (2009b) Metabotropic glutamate receptor type 5 in levodopa-induced motor complications. Neurobiol Aging. doi: 10.1016\/j.neurobiolaging.2009.07.014","DOI":"10.1016\/j.neurobiolaging.2009.07.014"},{"key":"526_CR32","volume-title":"Rat Brain in Stereotaxic Coordinates","author":"G Paxinos","year":"1982","unstructured":"Paxinos G, Watson C (1982) Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney"},{"key":"526_CR33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2005.03.028","volume":"514","author":"M Pietraszek","year":"2005","unstructured":"Pietraszek M, Sukhanov I, Maciejak P, Szyndler J, Gravius A, Wislowska A, Plaznik A, Bespalov AY, Danysz W (2005) Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats. Eur J Pharmacol 514:25\u201334","journal-title":"Eur J Pharmacol"},{"key":"526_CR34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.nbd.2010.05.001","volume":"39","author":"D Rylander","year":"2010","unstructured":"Rylander D, Iderberg H, Li Q, Dekundy A, Zhang J, Li H, Baishen R, Danysz W, Bezard E, Cenci MA (2010) A mGluR5 antagonist under clinical development improves l-DOPA-induced dyskinesia in parkinsonian rats and monkeys. Neurobiol Dis 39:352\u2013361","journal-title":"Neurobiol Dis"},{"key":"526_CR35","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.neurobiolaging.2007.02.005","volume":"29","author":"P Samadi","year":"2008","unstructured":"Samadi P, Gregoire L, Morissette M, Calon F, Hadj TA, Dridi M, Belanger N, Meltzer LT, Bedard PJ, Di PT (2008) mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys. Neurobiol Aging 29:1040\u20131051","journal-title":"Neurobiol Aging"},{"key":"526_CR36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.neuropharm.2006.05.004","volume":"51","author":"N Sevostianova","year":"2006","unstructured":"Sevostianova N, Danysz W (2006) Analgesic effects of mGlu1 and mGlu5 receptor antagonists in the rat formalin test. Neuropharmacology 51:623\u2013630","journal-title":"Neuropharmacology"},{"key":"526_CR37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2009.12.039","volume":"639","author":"A Simonyi","year":"2010","unstructured":"Simonyi A, Schachtman TR, Christoffersen GR (2010) Metabotropic glutamate receptor subtype 5 antagonism in learning and memory. Eur J Pharmacol 639:17\u201325","journal-title":"Eur J Pharmacol"},{"key":"526_CR38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0014-2999(00)00697-X","volume":"406","author":"WP Spooren","year":"2000","unstructured":"Spooren WP, Gasparini F, Bergmann R, Kuhn R (2000) Effects of the prototypical mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats. Eur J Pharmacol 406:403\u2013410","journal-title":"Eur J Pharmacol"},{"key":"526_CR39","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1097\/00001756-199708180-00012","volume":"8","author":"A Valerio","year":"1997","unstructured":"Valerio A, Paterlini M, Boifava M, Memo M, Spano P (1997) Metabotropic glutamate receptor mRNA expression in rat spinal cord. Neuroreport 8:2695\u20132699","journal-title":"Neuroreport"},{"key":"526_CR40","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1021\/jm0611298","volume":"51","author":"M Vanejevs","year":"2008","unstructured":"Vanejevs M, Jatzke C, Renner S, Muller S, Hechenberger M, Bauer T, Klochkova A, Pyatkin I, Kazyulkin D, Aksenova E, Shulepin S, Timonina O, Haasis A, Gutcaits A, Parsons CG, Kauss V, Weil T (2008) Positive and negative modulation of group I metabotropic glutamate receptors. J Med Chem 51:634\u2013647","journal-title":"J Med Chem"},{"key":"526_CR41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-005-2143-4","volume":"179","author":"GB Varty","year":"2005","unstructured":"Varty GB, Grilli M, Forlani A, Fredduzzi S, Grzelak ME, Guthrie DH, Hodgson RA, Lu SX, Nicolussi E, Pond AJ, Parker EM, Hunter JC, Higgins GA, Reggiani A, Bertorelli R (2005) The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles. Psychopharmacology (Berl) 179:207\u2013217","journal-title":"Psychopharmacology (Berl)"},{"key":"526_CR42","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1212\/WNL.50.5.1323","volume":"50","author":"ML Verhagen","year":"1998","unstructured":"Verhagen ML, Del DP, van den Munckhof P, Fang J, Mouradian MM, Chase TN (1998) Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson\u2019s disease. Neurology 50:1323\u20131326","journal-title":"Neurology"},{"key":"526_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0028-3908(00)00113-1","volume":"40","author":"K Walker","year":"2001","unstructured":"Walker K, Bowes M, Panesar M, Davis A, Gentry C, Kesingland A, Gasparini F, Spooren W, Stoehr N, Pagano A, Flor PJ, Vranesic I, Lingenhoehl K, Johnson EC, Varney M, Urban L, Kuhn R (2001) Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain. Neuropharmacology 40:1\u20139","journal-title":"Neuropharmacology"},{"key":"526_CR44","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.neuroscience.2009.07.060","volume":"163","author":"N Yamamoto","year":"2009","unstructured":"Yamamoto N, Soghomonian JJ (2009) Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats. Neuroscience 163:1171\u20131180","journal-title":"Neuroscience"},{"key":"526_CR45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(97)01106-2","volume":"777","author":"MR Young","year":"1997","unstructured":"Young MR, Fleetwood-Walker SM, Dickinson T, Blackburn-Munro G, Sparrow H, Birch PJ, Bountra C (1997) Behavioural and electrophysiological evidence supporting a role for group I metabotropic glutamate receptors in the mediation of nociceptive inputs to the rat spinal cord. Brain Res 777:161\u2013169","journal-title":"Brain Res"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-010-0526-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-010-0526-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-010-0526-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T23:19:40Z","timestamp":1559863180000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-010-0526-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,16]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["526"],"URL":"https:\/\/doi.org\/10.1007\/s00702-010-0526-0","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,16]]}}}